PharVision Advisers’s Centrus Energy LEU Stock Holding History

PharVision Advisers’s Portfolio LEU Stock Details LEU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,033	Closed	-$251K	–	399
2025 Q4	$251K	Buy	+1,033	New	+$312K	0.13%	386

Other funds holding LEU

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PharVision Advisers's LEU Position: Q1 2026 in Review

PharVision Advisers sold out of Centrus Energy (LEU) in Q1 2026, closing a stake of 1,033 shares — an estimated $251K sold.

PharVision Advisers first reported a position in LEU in Q4 2025 and held it in 1 quarter. The position peaked at $251K in Q4 2025. 393 funds tracked by Wall St. Rank hold LEU as of Q1 2026.

PharVision Advisers reported no remaining Centrus Energy position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 1,033 Centrus Energy shares in Q1 2026, an estimated $251K.
PharVision Advisers first reported a position in Centrus Energy in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Centrus Energy position peaked at $251K in Q4 2025.
393 funds tracked by Wall St. Rank held Centrus Energy as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.